SOCIAL MEDIA TOOLKIT October 1718 2018 San Francisco overview This toolkit gives you everything you need to discuss the 2018 BIF on social media particularly on Twitter and Facebook We encourage you to mentiontag ID: 1007150
Download Presentation The PPT/PDF document "2018 BIO Investor Forum" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. 2018 BIO Investor ForumSOCIAL MEDIA TOOLKIT October 17-18, 2018 • San Francisco
2. overviewThis toolkit gives you everything you need to discuss the 2018 BIF on social media, particularly on Twitter and Facebook. We encourage you to mention/tag #BIF18 and @IAmBiotech as you share content leading up to, during and after the event. Please use all or part of this kit to augment/supplement your existing social media plans for BIF 2018. Any irrelevant information should be discarded.With the exciting line up of speakers, endless networking opportunities and rich discussions on key issues affecting our industry and future, there will be many opportunities to share relevant and informative content to drive engagement and awareness of the work to which we are so proud to contribute.
3. Hashtags & HandlesBIO HANDLES Twitter @IAmBiotech @BIO1x1Facebook IAmBiotechHASHTAGS#BIF18Key VoicesJim Greenwood @JimGreenwood (Twitter) @jamesgreenwood (Facebook)
4. 2018 BIO Investor ForumPre-event Social Posts
5. Suggested post #1BIO Investor Forum#BIF18Caption suggestionsReady for #BIF18! Are you attending?Heading to #BIF18 in #SanFrancisco. Follow along @IAmBiotechExcited to see [insert speaker twitter handle] at #BIF18To use: Right click and save as picture
6. Suggested post #2Examples for Blank 1: @angelemaki , or @ThirdRockV or any individual or organization you chooseExamples for Blank 2: Giving a company presentation or meeting with new partners Suggested Caption Copy: #Goals #BIF18 #BiotechTo use: Double click the text to edit. Right click and save as picture This week at #BIF18, we’re most excited to hear from ________ and you can expect to see us __________.
7. Suggested post #3I just registered for @IamBiotech #BIF18-best conference to network with execs and investors focused exclusively on life sciences. www.bio.org/investorforumPositive investment trends for life sciences—looking forward to @IamBiotech #BIF18 for networking and market outlookI just registered for @IamBiotech #BIF18-best conference to network with execs and investors focused exclusively on life sciences. http://bit.ly/2xAVi2ITo use: Double click the text to edit. Right click and save as picture
8. Suggested post #4Just signed up for partnering @IAmBiotech #BIF18. Last year 2760 meeting were scheduled. www.bio.org/events/bio-investor-forum/partneringI just signed up for partnering @IAmBiotech #BIF18 for face-to-face meetings exploring deals, trends and opportunities https://www.bio.org/events/bio-investor-forum/partneringTo use: Right click and save as picture
9. 2018 BIO Investor ForumDuring event Social Posts
10. 2018 BIF Program- Wed, oct 17NameDescriptionPanelistsTimeRelevant Twitter HandlesNavigating Checkpoint Inhibitors’ Clinical Results: Lessons for CEOs and InvestorsThis panel reviews the current landscape of checkpoint inhibitor developmentAngele Maki, Merck & Co.Karin Jooss, Gritstone OncologyEugene P. Kennedy, New Link8:30 – 9:40 AM@angelemaki @Merck @gritstoneonc@NLNKGeneticsLearning from Translational Research Successes to Attract InvestmentExploring options to reduce the “valley of death” funding challengeSimone Fishburn, BioCenturyKevin Grimes, Stanford UnivStephanie Marrus, UCSFPaul Laikind, ViaCyte9:45 – 10:40 AM@FishburnSimone @Stanford@skmarrus @UCSF@ViaCyte Using Microbiome-Based Therapies to Improve Patient Outcomes Discussion of microbiome-based approaches to improve patient outcomesDavid Berry, FlagshipKarim Dabbagh, Second GenomeGlyn Edwards, Summit TherapeuticsLihi Segal, Day TwoEmma Taylor, Naked BiomePaul Miller, Synlogic10:45 – 11:40 AM@FlagshipPioneer@karimdabbagh@Summitplc@NakedBiome @synlogic_tx Fireside Chat12:00 – 1:45 PMReaching Chinese Investors: Considerations for an IPO in Hong Kong Cross-border perspectives on the appetite of China-based investors for biotechs Joshua Berlin, BioCenturyKatherine Andersen, SVBJie D’Elia, BMSMichael Keyoung, C-Bridge Capital2:00 – 2 :55 PM@BioPharmaJosh @SVB_Financial @bmsnewsCFIUS and You: Understanding the Newly Expanded Regulatory Reviews of Cross-Border InvestmentsImpact of new rules for foreign direct investment. Louis Lehot, DLA PiperMark E. Plotkin, Covington & Burling3:15 – 4:10 PM@lehotlouis@CovingtonLLP View from the Board: Responding to an Acquisition Offer Discussion on one of the greatest challenges faced by a leadership team: responding to an acquisition offer. Corey Goodman, venBioCamille Samuels, VenrockNina Kjellson, Canaan PartnersLinda Grais, Ocera Therapeutics4:15-5:10 PM@CamiSamuelsVC@nkjellson
11. 2018 BIF Program- Thurs, oct 18NameDescriptionPanelistsTimeRelevant Twitter HandlesExpanding the Toolbox of Neurodegeneration Therapies The promise of anti-beta amyloid antibody in slowing cognitive decline in Alzheimer’s patientsCharles S. Ryan, NeurotropeCarole Ho, DenaliRobert Paul, AlectorSteven Braithwaite, AlkahestJulie Anne Smith, E-Scape BioEmile Nuwaysir, BlueRock8:30 – 9:40 AM@Neurotrope1 @Denalitx@BlueRockTx Accelerating Biotech R&D Through Cloud ComputingDiscussion on the use of cloud computing in biotechnology researchElliot Menschik, AmazonCraig Muir, Third Rock9:45 – 10:40 AM@elliotmenschik@ThirdRockV“Digiceuticals” as a New Class of FDA-Approved Therapeutics: Investment & Partnering OpportunitiesRegulatory approach to digital therapeuticsDavid Klein, ClickChristopher Guiffre, Pear Jeffrey Abraham, Akili Interactive10:45 – 11:40 AM@ClickThera@Pear_Tx @AkiliLabs Fireside Chat with Rowan ChapmanHead of Johnson & Johnson Innovation, CARowan Chapman, J&J12:00 – 1:25@JNJNews How Real-World Evidence Can Improve Clinical Trial ProductivityClinical trial design may be enhanced by digital real world data sourcesKen Carson, FlatironChristine Lemke, EvidationGracie Lieberman, GenentechKomathi Stem, monARC Bionetworks1:45 – 2:40 PM@flatironhealth @cklemke @Genentech@monARCbioApplying Artificial Intelligence to Improve Therapy Development Today Folding AI techniques into the development of new therapiesEdward Painter, A2A ParmaJosep Bassaganya-Riera, LandosJeffrey Brewer, Bigfoot3:00 – 3:55 PM@LandosBio@BigfootBiomed Market Outlook – IPOs Ascendant and Watching M&A Valuations 2018 record flow of public and private offerings to biopharma and current deals and market trends4:00 – 4:55 PM
12. “LOREM IPSUM DOLOR SIT AMET, CONSECTETUR DOLOR ADIPISCING ELIT, SED DO EIUSMOD TEMPOR CONSECT INCIDIDUNT UT LABORE ETE DOLORE MAGNA ALIQUA. UT ENIM AD MINIM VENIAM, QUIS NOSTRUD EXERTION.” #BIF18 @IAmBiotech@nkjellson- General Partner, Canaan PartnersTo use: Double click the text to edit. Right click and save as picture Click here to access speakers headshot photos